Clinical Trial

Hydrogel Assessment for Local Treatment of Osteoarthritis

Study acronym: HALO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the safety and tolerability of one intra-articular injection of Hydrogel OA 2% for the symptomatic treatment of osteoarthritis of the knee.
Protocol Amendment History 5 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-15
notable Primary completion moved earlier: 2026-12-31 -> 2026-10-15 2026-07-15
minor Completion moved earlier: 2027-09-30 -> 2027-07-15 2026-07-15
critical Recruitment opened 2026-04-28
critical Primary endpoint(s) modified 2026-04-14
Trial Details
NCT Number NCT07516457
Lead Sponsor Allegro NV/SA
Conditions Osteo Arthritis of the Knee
Enrollment 20 participants
Start Date 2026-04-17
Primary Completion 2026-10-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-14